Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02401815
Recruitment Status : Active, not recruiting
First Posted : March 30, 2015
Last Update Posted : October 15, 2019
Sponsor:
Information provided by (Responsible Party):
Plexxikon

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : March 2021